Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Celecoxib (Celebrex): 1 year later.

McMorran M, Morawiecka I.

CMAJ. 2000 Apr 4;162(7):1044-6, 1048-50. English, French. No abstract available.

2.

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.

Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.

Am J Gastroenterol. 2001 Apr;96(4):1019-27.

PMID:
11316141
3.

Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.

Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S.

Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):366-76.

PMID:
16897817
4.

Celecoxib-induced fixed drug eruption.

Bandyopadhyay D.

Clin Exp Dermatol. 2003 Jul;28(4):452. No abstract available.

PMID:
12823316
5.

[Celecoxib induced toxiderma with positive patch-test].

Verbeiren S, Morant C, Charlanne H, Ajebbar K, Caron J, Modiano P.

Ann Dermatol Venereol. 2002 Feb;129(2):203-5. French.

6.

[Gastroduodenal tolerance of celecoxib (celebrex) in patients with osteoarthrosis: an endoscopic evaluation].

Karateev AE.

Ter Arkh. 2001;73(5):63-4. Russian. No abstract available.

PMID:
11517755
7.

[Hyperkalemia and celecoxib].

Rego MJ, Fonseré N, Martí S, Rey-Joly C.

Med Clin (Barc). 2002 Jun 8;119(1):36-7. Spanish. No abstract available.

PMID:
12062005
8.

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.

Phelan KM, Mosholder AD, Lu S.

J Clin Psychiatry. 2003 Nov;64(11):1328-34. Review.

PMID:
14658947
9.

Anaphylaxis to celecoxib.

Levy MB, Fink JN.

Ann Allergy Asthma Immunol. 2001 Jul;87(1):72-3.

PMID:
11476468
10.

[Anaphylactic shock induced by celecoxib].

Habki R, Vermeulen C, Bachmeyer C, Charoud A, Mofredj A.

Ann Med Interne (Paris). 2001 Sep;152(5):355. French. No abstract available.

PMID:
11593149
11.

Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation.

Kleinhans M, Linzbach L, Zedlitz S, Kaufmann R, Boehncke WH.

Contact Dermatitis. 2002 Aug;47(2):100-2.

PMID:
12423408
12.

Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).

Friedman B, Orlet HK, Still JM, Law E.

South Med J. 2002 Oct;95(10):1213-4.

PMID:
12425513
13.

[Toxic epidermal necrolysis and celecoxib (Celebrex)].

Schmutz JL, Barbaud A, Trechot P.

Ann Dermatol Venereol. 2004 Jan;131(1 Pt 1):107. French. No abstract available.

PMID:
15041861
14.

Safety of celecoxib in patients with adverse reactions to nimesulide.

Liccardi G, D'Amato G, Canonica GW, Lobefalo G, Noschese P, Piccolo A, Salzillo A, Passalacqua G.

Allergy. 2005 May;60(5):708-9. No abstract available.

15.

[Celebrex: confirmed effectiveness and safety (new data)].

Nasonov EL.

Ter Arkh. 2001;73(5):57-61. Review. Russian. No abstract available.

PMID:
11517753
16.

Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib.

Markowitz GS, Falkowitz DC, Isom R, Zaki M, Imaizumi S, Appel GB, D'Agati VD.

Clin Nephrol. 2003 Feb;59(2):137-42.

PMID:
12608557
17.

Are rofecoxib and celecoxib safer NSAIDS?

[No authors listed]

Drug Ther Bull. 2000 Nov;38(11):81-6. Review.

PMID:
11138599
18.

Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.

Crawford AS, White JG.

South Med J. 2002 Dec;95(12):1444-6.

PMID:
12597315
19.

COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database.

Durrieu G, Olivier P, Montastruc JL; French networks of Pharmacovigilance centers..

Eur J Clin Pharmacol. 2005 Sep;61(8):611-4. Epub 2005 Aug 24.

PMID:
16133552
20.

Celecoxib-induced photoallergic drug eruption.

Yazici AC, Baz K, Ikizoglu G, Kokturk A, Uzumlu H, Tataroglu C.

Int J Dermatol. 2004 Jun;43(6):459-61.

PMID:
15186233

Supplemental Content

Support Center